Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 601–700 of 933
Maternal Problem Drinking and Child Mental Health
Husky, M. M., Keyes, K. M., Hamilton, A. D., Stragalinou, A., Pez, O., Kuijpers, R., Lesinskienė, S., Mihova, Z., Otten, R., & Kovess–Masféty, V. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1312448 · Cited by 10
Anxiety Disorders and Suicide: Psychiatric Interventions
Hocaoğlu, Ç. (2015) · InTech eBooks · doi:10.5772/60594 · Cited by 5
Preuss, U. W., Hesselbrock, M. N., & HESSELBROCK, V. M. (2023) · Brain Sciences · doi:10.3390/brainsci13081130 · Cited by 7
Li, Y., Liu, X., Li, J., Zhang, Q., Pan, N., Luo, K., Kemp, G. J., & Gong, Q. (2025) · Psychological Medicine · doi:10.1017/s0033291725101141 · Cited by 6
“Epidemiologic studies indicated that 35.7% of cocaine users have a lifetime history of depression (Conway, Compton, Stinson, & Grant, 2006; Glasner-Edwards et al., 2009), and depressive symptoms among methamphetamine users are even more severe and persistent compared to cocaine users (Kay-Lambkin…”
InfluentialZech, J. M., Patel, T. A., & Cougle, J. R. (2025) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2025.103060 · Cited by 6
Cessation of self-reported opioid use and impacts on co-occurring health conditions
Scheidell, J. D., Townsend, T., Ban, K. F., Caniglia, E. C., Charles, D. L., Edelman, E. J., Marshall, B. D. L., Gordon, A. J., Justice, A. C., Braithwaite, R. S., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109712 · Cited by 6
Kim, I., Park, Y., Chasek, C. L., Bjornsen, A. L., & Shin, K. (2024) · Journal of Addictions & Offender Counseling · doi:10.1002/jaoc.12136 · Cited by 6
Qiu, L., Liang, C., Kochunov, P., Hutchison, K. E., Sui, J., Jiang, R., Zhi, D., Vergara, V. M., Yang, X., Zhang, D., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03035-2 · Cited by 8
“Alcohol and tobacco use are very common in psychiatric disorders that increase the mortality risk [8 – 10].”
BackgroundOtten, R., van der Zwaluw, C. S., & Engels, R. C. M. E. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.08.003 · Cited by 5
Martin, C. E., Scialli, A. C., & Terplan, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816569-0.00003-6 · Cited by 6
Regulation of glutamate signaling in the extended amygdala by adolescent alcohol exposure
Holmgren, E. B., & Wills, T. A. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.08.004 · Cited by 7
Complex Interactions Between Sex and Stress on Heroin Seeking
Carter, J. S., Kearns, A. M., & Reichel, C. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.784365 · Cited by 7
“To better understand this phenomenon, we used restraint stress to study anxiety-like behaviors and cognitive function in rodents (Yamamoto et al., 2009; Deslauriers et al., 2018) and classically conditioned a neutral odor with the stress experience in male and female rats.”
MethodMetz, V. G., da Rosa, J. L. O., Rossato, D. R., Bürger, M. E., & Pase, C. S. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173427 · Cited by 6
Bahji, A., Bastien, G., Bach, P., Choi, J., Foll, B. L., Lim, R., Jutras‐Aswad, D., & Socias, M. E. (2023) · The Canadian Journal of Psychiatry · doi:10.1177/07067437231194385 · Cited by 5
Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse
Fogelman, N., Tate, M. S., Wemm, S., Sullivan, L., Hart, R. L. D., Vacey, E., Fox, H. C., & Sinha, R. (2024) · Addiction Biology · doi:10.1111/adb.13390 · Cited by 7
“This was surprising given prior literature suggesting a relationship between these factors and substance use 16,17,67 and the strong relationship between these variables and both stress/trauma and drug craving, which were significant.”
BackgroundResultKarisetty, B. C., Duscharla, D., Vijay, V., Patel, S., Soren, K., Kumar, A., Ummanni, R., & Chakravarty, S. (2024) · Journal of Proteins and Proteomics · doi:10.1007/s42485-024-00145-9 · Cited by 6
“Approximately 30–40% of individuals with addictive disorders also have mood or anxiety disorders concurrently (Conway et al. 2006).”
A qualitative study of psychological stress and coping among persons using crack cocaine
Duopah, Y. A., Moran, L., Elmusharaf, K., & Kelly, D. (2024) · BMC Psychology · doi:10.1186/s40359-024-02032-w · Cited by 8
“Compared to powder cocaine, crack cocaine use has been linked to a higher number of psychiatric indicators and psychiatric comorbidities such as depression, anxiety, paranoia, psychosis, antisocial personality disorder and suicide attempts [17–19].”
BackgroundMusso, L. B., Mann, R., Strıke, C., Brands, B., & Khenti, A. (2012) · Texto & Contexto - Enfermagem · doi:10.1590/s0104-07072012000500015 · Cited by 5
“1996 Jun; 32(3):291-306; discussion 307-10.”
Bone mineral density in a cohort of Estonian women with major depression
Sommerhage, V., Kull, I., Schweiger, U., & Rudolf, S. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0163-y · Cited by 5
Thoradeniya, M. R., Leslie, E. M., Pourmarzi, D., Najman, J. M., & Smirnov, A. (2020) · Drug and Alcohol Review · doi:10.1111/dar.13196 · Cited by 6
Work experiences, resources, and beliefs among vulnerable subgroups of mental health care users
Eklund, M., Jansson, J.-Å., Eklund, L., Pooremamali, P., & Gunnarsson, A. B. (2021) · Work · doi:10.3233/wor-213559 · Cited by 6
“People with substance use disorder (SUD) form another vulnerable group [12].”
BackgroundReductions of p11 and 5-HT1B Receptor Availability in Limbic Brain Regions in Cocaine Dependence
Svenningsson, P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.011 · Cited by 5
Effect of Short-Term Separation on the Behavioral Health of Military Wives
Oblea, P. N., Badger, T. A., & Hopkins-Chadwick, D. L. (2016) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20160518-07 · Cited by 8
Margolis, A., Rosca, P., Kurs, R., Sznitman, S. R., & Grinshpoon, A. (2016) · Journal of Dual Diagnosis · doi:10.1080/15504263.2016.1252075 · Cited by 4
Raftery, D., Kelly, P. J., Deane, F. P., Baker, A., Dingle, G. A., & Hunt, D. (2019) · Journal of Substance Use · doi:10.1080/14659891.2019.1664654 · Cited by 6
“Given the strong comorbidity of mental health problems and substance use dependence (Conway et al., 2006; National Institute on Drug Abuse, 2010), alongside the negative impact psychological distress can have on recovery from addiction, it is important for research to examine the role addiction…”
BackgroundWhat Treatments Are Effective for Anxiety in Patients With Serious Illness?
Irwin, S. A., Montross, L. P., & Chochinov, H. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-3796-7.00034-3 · Cited by 7
Computerized Trans-Diagnostic Dialectical Behavior Therapy Skills Training for Emotion Dysregulation
Lungu, A. (2015) · ResearchWorks at the University of Washington (University of Washington) · Cited by 9
The Opioid Crisis: A Contextual Framework and Call for Systems Science ResearchPreprint
Jalali, M. S., Botticelli, M. P., Hwang, R. C., Koh, H. K., & McHugh, R. K. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3407952 · Cited by 5
Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing
McHugh, R. K., Fitzmaurice, G. M., Votaw, V. R., Geyer, R. B., Ragnini, K., Greenfield, S. F., & Weiss, R. D. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209296 · Cited by 9
Snaychuk, L. A., Hirst, S. A., & Basedow, C. A. (2023) · Journal of Substance Use · doi:10.1080/14659891.2023.2173095 · Cited by 6
“All of the aforementioned variables have been previously implicated as predictors of cravings in prior literature (Choopan et al., 2016; Conway et al., 2006; Fox et al., 2007; Khosravani et al., 2017; McCaul et al., 2017; Szasz et al., 2012).”
BackgroundResultInfluentialJegede, O. O., Stefanovics, E. A., Rhee, T. G., & Rosenheck, R. A. (2023) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001625 · Cited by 4
Algarin, A. B., Yeager, S., Patterson, T. L., Strathdee, S. A., Vera, A., Vera, C. F., Stamos-Buesig, T., Artamanova, I., Abramovitz, D. A., & Smith, L. R. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109831 · Cited by 4
Mental health, substance use, and the importance of religion during the COVID-19 pandemic
Park, J.-Y., Galbadage, T., Lee, H., Wang, D., & Peterson, B. M. (2023) · Mental Health Religion & Culture · doi:10.1080/13674676.2023.2202382 · Cited by 5
“For example, studies have indicated that high rates of SUD have been observed concomitantly with anxiety disorders or depressive states (Conway et al., 2006; Wolitzky-Taylor et al., 2011).”
BackgroundCorrea, K. A., Delfel, E. L., Wallace, A. L., Pelham, W. E., & Jacobus, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1251032 · Cited by 6
Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations
Bahji, A., Crockford, D. N., Brasch, J. S., Schütz, C. G., Buckley, L., Danilewitz, M., Dubreucq, S., Mak, M. S. B., & George, T. P. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241231128 · Cited by 5
Functional brain connectivity of the salience network in alcohol use and anxiety disorders
Patel, D. M., Poblete, G. F., Castellanos, A., & Salas, R. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.045 · Cited by 5
Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
Ngo, A. L., Ahmad, C. M., Alkhansari, N. G., Nguyen, L., & Zhang, H. (2025) · Complex Psychiatry · doi:10.1159/000544912 · Cited by 8
“Substance-Induced Epigenetic Changes Linked to Psychiatric Conditions SUD frequently co-occurs with psychiatric disorders such as schizophrenia [195], depression [196, 197], stress [198], and anxiety [196, 199, 200].”
Psychological Distress and Problem Drinking
Mentzakis, E., Roberts, B., Suhrcke, M., & McKee, M. (2015) · Health Economics · doi:10.1002/hec.3143 · Cited by 8
Suicidal Behavior and Prescription Opioid Medication
Searles, V. B., & Davis, J. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00056-1 · Cited by 6
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Bogen, D. L., Altemus, M. M., Pearlstein, T. B., Svikis, D. S., Misra, D. P., & Miller, E. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00055-x · Cited by 5
Comorbidities within mental illnesses in a multiethnic urban population
Tan, X. W., Chong, S. A., Abdin, E., Vaingankar, J. A., Shafie, S., Zhang, Y., Chang, S. S. H., Shahwan, S., Heng, D., & Subramanian, M. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102018 · Cited by 6
Resolving Treatment Complications Associated with Comorbid Anxiety and Substance Use Disorders
Reynolds, E. K., Tull, M. T., Shalev, I., & Lejuez, C. W. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0612-0_15 · Cited by 4
“Although epidemiological studies tend to find higher prevalence rates for alcohol use disorders (alcohol abuse and/or dependence) than for drug use disorders, prevalence rates for both types of disorders are elevated in the context of an anxiety disorder when compared to individuals without an anxiety disorder diagnos…”
BackgroundTreatment of Cocaine Addiction
Gorelick, D. A. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_15 · Cited by 4
Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 8
Barberot, P., Gibaja, V., Benkhedda, C., Dobre, D., Tournebize, J., & Kahn, J. (2018) · Therapies · doi:10.1016/j.therap.2018.10.002 · Cited by 4
Increased relapse to cocaine‐seeking in a genetic model for depression
Zilkha, N., Barnea‐Ygael, N., Keidar, L., & Zangen, A. (2019) · Addiction Biology · doi:10.1111/adb.12756 · Cited by 4
“In the general population, major depression increases the risk of patients to suffer from comorbid cocaine dependence by more than twice.(4,45) In turn, this comorbidity reduces the chances of abstinence,”
BackgroundRobinson, M. J. F., Caplan, K. A., Knes, A. S., Cruz, H. O. R., Clibanoff, C., & Freeland, C. M. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109795 · Cited by 4
Neurobiological and neuropsychological pathways into substance abuse and addictive behavior
Yücel, M., Lubman, D. I., Solowij, N., & Brewer, W. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511642197.027 · Cited by 5
Reflections on 40 Years of Drug Abuse Research: Changes in the Epidemiology of Drug Abuse
Clayton, R. R., Sloboda, Z., & Page, B. (2009) · Journal of Drug Issues · doi:10.1177/002204260903900105 · Cited by 4
Abbas, M. J., Ward, T., Peivandi, M. H., McKenzie, E., Kujawska-Debiec, K., & Hills, A. (2015) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2014.95 · Cited by 4
“Drug and alcohol problems are particularly prevalent in psychiatric inpatients (Conway et al. 2006).”
BackgroundEngagement of Pleasant Activities in Patients with Substance Use Disorders: A Correlational Study
Roozen, H. G., Strietman, M., Wiersema, H., Meyers, R. J., Lewinsohn, P. M., Feij, J. A., Greeven, P. G. J., Vingerhoets, A. J. J. M., & van den Brink, W. (2014) · Substance Abuse · doi:10.1080/08897077.2013.873760 · Cited by 5
Correlates of recent drug use among victimized women on probation and parole.
Golder, S., Hall, M. T., Engstrom, M., Higgins, G. E., & Logan, T. (2014) · Psychology of Addictive Behaviors · doi:10.1037/a0038351 · Cited by 4
Clinical Management of Major Depressive Disorder
Mignon, L., & Stahl, S. M. (2009) · CNS Spectrums · doi:10.1017/s1092852900003837 · Cited by 6
Rothberg, B., & Schneck, C. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10047-8 · Cited by 4
Khazaee-Pool, M., Arefi, Z., Roshani, D., Pashaei, T., & Ponnet, K. S. (2017) · BMC Public Health · doi:10.1186/s12889-017-4911-6 · Cited by 4
“Aside from physical harm, previous studies have also shown that people with opioid use disorders have higher risks of panic disorders, social phobia, agoraphobia, low self-reported health, lifetime anxiety, and mood disorders [2, 9, 10].”
Rarani, M. A., Morasae, E. K., Pashaei, T., & Moeeni, M. (2020) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-00299-x · Cited by 7
Illicit Drug Use Across The Anxiety Disorders
Tull, M. T., Baruch, D. E., Duplinsky, M. S., & Lejuez, C. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-74753-8_3 · Cited by 6
Predictors of Depressive and Anxiety Symptoms among African American HIV-positive Women
Sublette, N. K. (2008) · doi:10.21007/etd.cghs.2008.0303 · Cited by 5
Wilkialis, L., Kim, S., Hassan, A. N., & Foll, B. L. (2025) · Cannabis and Cannabinoid Research · doi:10.1177/25785125251363122 · Cited by 3
“43,44 In our own sample, alcohol, opioid, and stimulant use disorders were the most common, a similar trend often seen in individuals with mood disorders, 45,46 suggesting greater vulnerability to multi-substance use in mood disorder populations.”
Edwards, C. M., Xu, Z., & Winder, D. G. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06925-5 · Cited by 4
“Women report more mentally unhealthy days following binge drinking compared to men (Wen et al. 2012) and women with AUD tend to have more comorbid psychiatric disorders (Conway et al. 2006; Greenfield et al. 2010; Hilderbrand and Lasek 2018).”
InfluentialFactors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users
Lo, L. A., MacCallum, C. A., Yau, J. C., Panenka, W. J., & Barr, A. M. (2022) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2022.22358 · Cited by 4
“22 The links between cannabis use and mental health are complex, and establishing directionality remains an ongoing challenge.”
BackgroundChapter 55. Treatment of Alcohol Use Disorder
Mason, B. J., Ritvo, E. C., & Bonci, A. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as55 · Cited by 3
Wolfson, C., Angelson, J. T., & Creanga, A. A. (2025) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-024-00198-0 · Cited by 5
Garrison‐Desany, H. M., Meyers, J. L., Linnstaedt, S. D., Koenen, K. C., House, S. L., Beaudoin, F. L., An, X., Neylan, T. C., Clifford, G. D., Jovanović, T., et al. (2025) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-025-02821-7 · Cited by 3
Pro, G. C., Neighbors, H. W., Wilkerson, B., & Haynes, T. F. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.117843 · Cited by 5
Bertholomey, M. L., Forbes, C., McElroy, B. D., & Torregrossa, M. M. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06782-2 · Cited by 3
Taggart, N., Kinner, S. A., & Young, J. T. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112675 · Cited by 6
Qualidade de vida e ansiedade relacionadas às alterações vocais: revisão sistemática
Martinez, C. C., Gurgel, L. G., Plentz, R. D. M., Reppold, C. T., & Cassol, M. (2015) · Estudos de Psicologia (Campinas) · doi:10.1590/0103-166x2015000300015 · Cited by 3
Major Depression and Sedative-Hypnotic Use Disorder: a Review
Chen, L., Kaufmann, C. N., & Mojtabai, R. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0218-7 · Cited by 4
Sex differences in an old adult sample with substance use disorder: A 6 months follow-up study
Ros‐Cucurull, E., Palma-Álvarez, R. F., Daigre, C., Jacas, C., Perea-Ortueta, M., Sorribes-Puertas, M., Quesada‐Franco, M., Martínez-Arias, R., Ros-Montalbán, S., Casas, M., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.10.041 · Cited by 3
Can Adult Neurogenesis Be Considered as Neuroplasticity?
Famitafreshi, H., & Karimian, M. (2019) · Archives of Neuroscience · doi:10.5812/ans.79812 · Cited by 3
“An important point in this regard is that many psychiatric diseases co-morbid with another one (50-52).”
BackgroundŞenormancı, G., Turan, Ç., Çelik, S., Çelik, A., Edgünlü, T., Akbaş, D., Akça, A. S. D., & Şenormancı, Ö. (2020) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2020.1785361 · Cited by 3
“According to National Epidemiologic Data, the lifetime depression rate was 41.6% in individuals with amphetamine abuse or dependence (Conway et al., 2006).”
BackgroundInfluentialDyar, C., Bradley, H. M., Morgan, E., Sullivan, P. S., & Mustanski, B. S. (2020) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2020.81.790 · Cited by 4
“Among the general adult population, substance use and depression are highly comorbid, with 41% of individuals with substance use disorders having comorbid mood disorders compared with only 19% of those without substance use disorders (Conway et al., 2006).”
BackgroundConsumo de substancias durante el embarazo y dimensiones de personalidad
Imaz, M. L., Navinés, R., Gelabert, E., Fonseca, F., Gutiérrez‐Zotes, A., Guillamat, R., Langohr, K., Cañellas, F., Gornemann, I., Costas, J., et al. (2020) · Adicciones · doi:10.20882/adicciones.1433 · Cited by 9
Blair, C. S., Needleman, J., Javanbakht, M., Comulada, W. S., Ragsdale, A., Bolan, R., SHOPTAW, S. J., & Gorbach, P. M. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001568 · Cited by 3
“Correlated error terms were limited to repeated measures of the same variable and methamphetamine use with depressive symptoms at the same timepoint, because the literature demonstrates that there is a relationship between methamphetamine and depression but the directionality is unclear.(25,26) Goodness of fit (GOF) w…”
MethodComorbid Anxiety and Alcohol or Substance Use Disorders: An Overview
Bartoli, F., Carretta, D., & Carrà, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_92 · Cited by 3
Ellis, J. D., Lister, J. J., Wohl, M. J. A., Greenwald, M. K., & Ledgerwood, D. M. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107604 · Cited by 4
Bed Nucleus of Stria Terminalis (BNST) circuits
Centanni, S. W., Brown, J. A., Williford, K. M., Flook, E. A., Luchsinger, J. R., & Winder, D. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823453-2.00011-4 · Cited by 4
Zhu, R., Wang, D., Fan, F., Fu, F., Wei, D., Tang, S., Tian, Y., Chen, J., Li, Y., Zhou, H., et al. (2023) · American Journal on Addictions · doi:10.1111/ajad.13476 · Cited by 3
Stanley, J. N., DeLucca, S. C., Perron, L., & Belenko, S. R. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209279 · Cited by 4
Mankiw, C., Whitman, E. T., Torres, E. N., Lalonde, F. M., CLASEN, L. S., Blumenthal, J. D., Chakravarty, M. M., & Raznahan, A. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102771 · Cited by 2
“…(Dougherty et al., 2016; Ho et al., 2019; Nolan et al., 2020), and (iii) subcortical systems are known to undergo sex-biased development en route to and during life-stages of initial exposure to alcohol (Dennison et al., 2013; Goddings et al., 2014; Raznahan et al., 2014; Wierenga et al., 2018).”
BackgroundFotiou, A., Kanavou, E., Richardson, C., & Kokkevi, A. (2014) · Nordic Studies on Alcohol and Drugs · doi:10.2478/nsad-2014-0029 · Cited by 5
Hoffman, L. A., Lewis, B., & Nixon, S. J. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1316291 · Cited by 3
Bennett, A. C., Gibson, C., Rohan, A., Howland, J. F., & Rankin, K. (2018) · Public Health Reports · doi:10.1177/0033354918812807 · Cited by 6
Morton, I., Hurley, B., Castillo, E. G., Tang, L., Gilmore, J. M., Jones, F., Watkins, K. E., Chung, B., & Wells, K. B. (2020) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1708085 · Cited by 4
Yi-qin, H., Zhai, J., & Liu, Y. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1736659 · Cited by 3
“In one North American epidemiological survey, a history of depression was reported by 41.6% of amphetamine adult users (Conway et al., 2006).”
BackgroundInfluentialIsenberg, B. M., Woodward, D. W., Burke, C. W., Nowinski, L. A., Joshi, G., & Wilens, T. E. (2021) · Research in Autism · doi:10.1016/j.rasd.2021.101728 · Cited by 5
Group Therapy for Substance Use Disorders
McHugh, R. K., Kim, J., Perrins, S. P., & Weiss, R. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_30 · Cited by 3
Vogel, M., Nikoo, M., Nikoo, N., Schütz, C. G., Walter, M., Somers, J. M., & Krausz, M. R. (2018) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-018-0040-4 · Cited by 4
“Large studies in general population samples also found associations between depression and stimulant or sedative use (Conway et al. 2006).”
BackgroundManagement of Comorbidity in Bipolar Disorder
Salloum, I. M., Pani, L., & Cooke, T. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch27 · Cited by 5
Quronfulah, B. S., Alzahrani, R. S., Kattan, E. T., Tamim, H. M., Alharbi, T. H., Alghamdi, M. M., & Badawoud, A. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307163 · Cited by 4
“Several clinical and nonclinical studies have reported that SAD predicts a heightened risk for depression [4, 26–29].”
BackgroundChatterton, M. L., Perez, J. K., Lee, Y. Y., Le, L. K., Birrell, L., Slade, T. N., Mewton, L. R., Hides, L. M., MCBRIDE, N. T., ALLSOP, S. J., et al. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01423-9 · Cited by 2
“This ignores the comorbidity and common risk factors shared by substance use and mental disorders (Berg et al., 2019; Conway et al., 2006).”
Nøst, T. H., Skurtveit, S. O., Odsbu, I., Pedersen, L., Borchgrevink, P. C., & Handal, M. (2024) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2024-0059 · Cited by 3
Managing treatment-resistant depression with comorbid substance use disorders
Stubbs, K. R., Bezooyen, J. V., & Tang, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00031-1 · Cited by 3
Byregowda, H., Amin‐Esmaeili, M., Susukida, R., Mojtabai, R., & Crum, R. M. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2606018 · Cited by 3
“Specifically, a high degree of comorbidity between SUDs and mood and/or anxiety disorders (M/AD) has been reported across national general population surveys (Compton et al., 2007; Conway et al., 2006; Grant et al., 2004; Pettinati et al., 2013).”
Peck, E. G., Emerson, S. D., Curry, A. M., Holter, K. M., Estave, P. M., Sens, J. P., Colarusso, O. A., Farris, S. P., Kiraly, D. D., Gould, R. W., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2518590123 · Cited by 3
“Anxiety - like behavior, a known predictor of increased cocaine intake and a frequent comorbidity in substance use disorders (26, 41–44), was reduced in Syngr3 - overexpressing rats, as evidenced by elevated exploration in both the open field and elevated plus maze.”
Pharmacotherapy of Dual Disorders
Soyka, M., & Grunze, H. (2014) · Springer eBooks · doi:10.1007/978-3-642-45375-5_19 · Cited by 2
The Role of Motivation in Cognitive Behavioural Psychotherapy for Anxiety Disorders
Heldt, E., Blaya, C., & Manfro, G. G. (2014) · Cross-cultural advancements in positive psychology · doi:10.1007/978-94-017-8669-0_7 · Cited by 2
Cocaine Addiction and Treatment
Gorelick, D. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_13 · Cited by 3
Salloum, I. M., & Christodoulou, G. N. (2016) · Springer eBooks · doi:10.1007/978-3-319-39724-5_26 · Cited by 2
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.